(Q36674058)

English

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols

scientific article published on January 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

rhabdomyosarcoma

1 reference

based on heuristic

inferred from title

author name string

R B Raney

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

H M Maurer

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J R Anderson

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R J Andrassy

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S S Donaldson

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S J Qualman

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M D Wharam

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

E S Wiener

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

W M Crist

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

9-15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Preservation of the bladder in patients with rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

The Intergroup Rhabdomyosarcoma Study-II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

The Intergroup Rhabdomyosarcoma Study-I. A final report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Primary reexcision for patients with 'microscopic residual' tumor following initial excision of sarcomas of trunk and extremity sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

30 September 2017

Molecular genetics and pathogenesis of rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

28 June 2018

P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

28 June 2018

Lymphatic mapping with sentinel node biopsy in pediatric patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2395450

20 September 2018

Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Third Intergroup Rhabdomyosarcoma Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III

1 reference

https://pubmed.ncbi.nlm.nih.gov/18521303

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/13577140120048890

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36674058&oldid=1804540583"